Drug Search Results

Edrecolomab

Alternative Names: edrecolomab, 17-1a
Latest Update: 2024-05-08
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: EPCAM Antagonist

Novel Mechanism: Yes

Modality: Antibody

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Germany

Approved Indications: None

Known Adverse Events: None

Company: Austrian Breast & Colorectal Cancer Study Group
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Edrecolomab

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Colorectal Cancer|Mucinous Cystadenocarcinoma|Mucinous Adenocarcinoma

Phase 2: Colorectal Cancer

Trial	Phase	Trial Status	Disease	Primary Completion Date
GWCC-5095	P2	Withdrawn	Colorectal Cancer	2017-02-22
NCI-2012-02826	P3	Completed	Mucinous Adenocarcinoma\|Mucinous Cystadenocarcinoma\|Colorectal Cancer	2003-07-01
ABSCG 92	P3	Terminated	Colorectal Cancer	None

Recent News Events

Date	Type	Title
05/08/2024	PubMed	Greatly isolated heterogeneous circulating tumor cells using hybrid engineered cell membrane-camouflaged magnetic nanoparticles.
05/08/2024	PubMed	MiRNA-192-5p-targeted activated leukocyte cell adhesion molecule improved inflammatory injury of neonatal necrotizing enterocolitis.
05/01/2024	PubMed	Single-cell analyzing of tumor microenvironment and cell adhesion between early and late-stage lung cancer.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions